Positive opinion paves way for first new treatment option in hidradenitis suppurativa (HS) in nearly a decade Committee for Medicinal Products for Human Use (CHMP) opinion based on robust Phase
Positive opinion paves way for first new treatment option in hidradenitis suppurativa in nearly a decade Committee for Medicinal Products for Human Use opinion based on robust Phase III data. | April 26, 2023